Funding for this research was provided by:
National Institute on Drug Abuse (R25DA13582, R25DA13582, R25DA13582, R25DA13582)
National Institute of Allergy and Infectious Diseases (P30AI042853, P30AI042853)
Received: 3 June 2021
Accepted: 2 June 2022
First Online: 17 June 2022
: All methods were carried out in accordance with relevant guidelines and regulations.No experimental procedures were conducted.We received an exemption determination under the policies and procedures of the Human Research Protection Program from the Boston University Medical Campus Institutional Review Board (no PHI collected, accessed, used or distributed under 45 CFR 164.514); informed consent was not applicable per the exempt determination.
: Not applicable.
: The authors declare that they have no competing interests.